These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7547090)

  • 21. Investigations into the potential effects of multiple dose ketorolac on the pharmacokinetics and pharmacodynamics of racemic warfarin.
    Toon S; Holt BL; Mullins FG; Bullingham R; Aarons L; Rowland M
    Br J Clin Pharmacol; 1990 Nov; 30(5):743-50. PubMed ID: 2271374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of naproxen on the steady-state serum concentration and anticoagulant activity of warfarin.
    Jain A; McMahon FG; Slattery JT; Levy G
    Clin Pharmacol Ther; 1979 Jan; 25(1):61-6. PubMed ID: 758244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of effect of pantoprazole on the pharmacodynamics and pharmacokinetics of warfarin.
    Duursema L; Müller FO; Schall R; Middle MV; Hundt HK; Groenewoud G; Steinijans VW; Bliesath H
    Br J Clin Pharmacol; 1995 Jun; 39(6):700-3. PubMed ID: 7654493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. No pharmacokinetic or pharmacodynamic interaction between rivastatin and warfarin.
    Schall R; Müller FO; Hundt HK; Ritter W; Duursema L; Groenewoud G; Middle MV
    J Clin Pharmacol; 1995 Mar; 35(3):306-13. PubMed ID: 7608323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of aprepitant on the pharmacokinetics and pharmacodynamics of warfarin.
    Depré M; Van Hecken A; Oeyen M; De Lepeleire I; Laethem T; Rothenberg P; Petty KJ; Majumdar A; Crumley T; Panebianco D; Bergman A; de Hoon JN
    Eur J Clin Pharmacol; 2005 Jul; 61(5-6):341-6. PubMed ID: 15983826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics and pharmacodynamics of warfarin when coadministered with pentosan polysulfate sodium.
    Modi NB; Kell S; Simon M; Vargas R
    J Clin Pharmacol; 2005 Aug; 45(8):919-26. PubMed ID: 16027402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Study of the effect of miglitol on the pharmacokinetics and pharmacodynamics of warfarin in healthy males.
    Schall R; Müller FO; Hundt HK; Duursema L; Groenewoud G; Middle MV
    Arzneimittelforschung; 1996 Jan; 46(1):41-6. PubMed ID: 8821516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of multiple doses of donepezil HCl on the pharmacokinetic and pharmacodynamic profile of warfarin.
    Tiseo PJ; Foley K; Friedhoff LT
    Br J Clin Pharmacol; 1998 Nov; 46 Suppl 1(Suppl 1):45-50. PubMed ID: 9839766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Moexipril does not alter the pharmacokinetics or pharmacodynamics of warfarin.
    Van Hecken A; Verbesselt R; Depré M; Tjandramaga TB; Angehrn J; Cawello W; De Schepper PJ
    Eur J Clin Pharmacol; 1993; 45(3):291-3. PubMed ID: 8276058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of cilostazol on the pharmacokinetics and pharmacodynamics of warfarin.
    Mallikaarjun S; Bramer SL
    Clin Pharmacokinet; 1999; 37 Suppl 2():79-86. PubMed ID: 10702890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of vinpocetine on warfarin-induced inhibition of coagulation.
    Hitzenberger G; Sommer W; Grandt R
    Int J Clin Pharmacol Ther Toxicol; 1990 Aug; 28(8):323-8. PubMed ID: 2272713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of diltiazem on warfarin plasma protein binding.
    Mungall DR; Ludden TM; Hawkins DW; Tabor TA; Penn DH; Crawford MH
    J Clin Pharmacol; 1984; 24(5-6):264-6. PubMed ID: 6747023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of photosensitising potential of tenidap, a novel anti-rheumatic agent.
    Ferguson J; Leeming MR
    Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):63S-66S. PubMed ID: 7547098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Tenidap, a novel anti-inflammatory compound on islet lymphocytic infiltration and diabetes incidence in the non obese diabetic (NOD) mouse.
    Beales PE; Williams A; Krug J; Signore A; Chianelli M; Andreani D; Pozzilli P
    Diabete Metab; 1992; 18(1):48-53. PubMed ID: 1563537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacodynamic and stereoselective pharmacokinetic interactions between zileuton and warfarin in humans.
    Awni WM; Hussein Z; Granneman GR; Patterson KJ; Dubé LM; Cavanaugh JH
    Clin Pharmacokinet; 1995; 29 Suppl 2():67-76. PubMed ID: 8620673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clofibrate displaces warfarin from plasma proteins in man: an example of a pure displacement interaction.
    Bjornsson TD; Meffin PJ; Swezey S; Blaschke TF
    J Pharmacol Exp Ther; 1979 Sep; 210(3):316-21. PubMed ID: 480183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.
    Jiang X; Williams KM; Liauw WS; Ammit AJ; Roufogalis BD; Duke CC; Day RO; McLachlan AJ
    Br J Clin Pharmacol; 2004 May; 57(5):592-9. PubMed ID: 15089812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cinacalcet does not affect the pharmacokinetics or pharmacodynamics of warfarin.
    Padhi D; Sullivan JT
    Drugs R D; 2007; 8(2):79-87. PubMed ID: 17324005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Warfarin in the dog: pharmacokinetics as related to clinical response.
    Neff-Davis CA; Davis LE; Gillette EL
    J Vet Pharmacol Ther; 1981 Jun; 4(2):135-40. PubMed ID: 7349326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stereoselective interaction between the R enantiomer of warfarin and cimetidine.
    Choonara IA; Cholerton S; Haynes BP; Breckenridge AM; Park BK
    Br J Clin Pharmacol; 1986 Mar; 21(3):271-7. PubMed ID: 2938614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.